Cardio Diagnostics (CDIO) director granted 3,205 options at $1.95

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Intrater James reported acquisition or exercise transactions in this Form 4 filing.

Cardio Diagnostics Holdings director James Intrater received a grant of 3,205 stock options on Common Stock at $1.95 per share. These options were granted on March 31, 2026 and expire on March 31, 2036. Following the award, he holds 10,464 stock options directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Intrater James

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Options (Right to Buy)	3,205	$1.95	$6K

Holdings After Transaction: Stock Options (Right to Buy) — 10,464 shares (Direct)

Footnotes (1)

Key Figures

Options granted: 3,205 options Exercise price: $1.95 per share Options after grant: 10,464 options +1 more

4 metrics

Options granted 3,205 options Stock options grant on March 31, 2026

Exercise price $1.95 per share Strike price of granted stock options

Options after grant 10,464 options Total stock options held following transaction

Option expiration March 31, 2036 Expiration date of granted stock options

Key Terms

Stock Options (Right to Buy), Common Stock, grant/award acquisition

3 terms

Stock Options (Right to Buy) financial

"security_title: "Stock Options (Right to Buy)""

Common Stock financial

"underlying_security_title: "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

grant/award acquisition financial

"transaction_action: "grant/award acquisition""

Form 4 Insider Transactions: What Each Field Means →

04/02/2026 - 02:08 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Intrater James

(Last)

(First)

(Middle)

C/O CARDIO DIAGNOSTICS HOLDINGS INC.

311 W. SUPERIOR ST. SUITE 444

(Street)

CHICAGO

ILLINOIS

60654

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Cardio Diagnostics Holdings, Inc. [ CDIO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Options (Right to Buy)	$1.95	03/31/2026		A		3,205		03/31/2026	03/31/2036	Common Stock	3,205	$1.95	10,464	D

Explanation of Responses:

	/s/ Elisa Luqman as attorney-in-fact for James Intrater	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did CDIO director James Intrater report?

Director James Intrater reported receiving a grant of 3,205 stock options. The options give him the right to buy Cardio Diagnostics common stock at $1.95 per share, reflecting compensation rather than an open-market purchase or sale.

What is the exercise price of the options granted to CDIO director Intrater?

The granted stock options carry an exercise price of $1.95 per share. This means Intrater can purchase Cardio Diagnostics common stock at $1.95, regardless of future market price, if he exercises before the options expire.

When do James Intrater’s Cardio Diagnostics stock options expire?

The stock options granted to James Intrater expire on March 31, 2036. He must exercise them on or before that date to purchase shares at the fixed $1.95 exercise price specified in the option award.

How many stock options does CDIO director Intrater hold after this grant?

After the March 31, 2026 grant, James Intrater holds 10,464 stock options directly. This total includes the newly awarded 3,205 options, all linked to Cardio Diagnostics common stock at the specified exercise price.

Is Intrater’s Form 4 transaction in CDIO shares a market buy or sell?

The Form 4 reflects a grant or award acquisition of stock options, not a market buy or sell of shares. Intrater received 3,205 options as compensation, giving him future rights to purchase common stock at $1.95 per share.